Mission Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.32M | Buy |
12,598
+7,843
| +165% | +$3.77M | 0.08% | 149 |
|
|
2026
Q1 | $2.34M | Buy |
4,755
+58
| +1% | +$31.5K | 0.05% | 195 |
|
|
2025
Q4 | $2.72M | Sell |
4,697
-25
| -0.5% | -$14.1K | 0.05% | 182 |
|
|
2025
Q3 | $2.29M | Sell |
4,722
-97
| -2% | -$45.1K | 0.05% | 202 |
|
|
2025
Q2 | $1.95M | Sell |
4,819
-232
| -5% | -$97K | 0.04% | 212 |
|
|
2025
Q1 | $2.51M | Buy |
5,051
+668
| +15% | +$362K | 0.06% | 168 |
|
|
2024
Q4 | $2.28M | Sell |
4,383
-313
| -7% | -$172K | 0.05% | 170 |
|
|
2024
Q3 | $2.9M | Buy |
4,696
+183
| +4% | +$108K | 0.07% | 142 |
|
|
2024
Q2 | $2.5M | Buy |
4,513
+187
| +4% | +$107K | 0.07% | 147 |
|
|
2024
Q1 | $2.51M | Buy |
4,326
+342
| +9% | +$192K | 0.07% | 157 |
|
|
2023
Q4 | $2.11M | Sell |
3,984
-172
| -4% | -$83.3K | 0.07% | 143 |
|
|
2023
Q3 | $2.1M | Buy |
4,156
+1,026
| +33% | +$547K | 0.08% | 127 |
|
|
2023
Q2 | $1.63M | Buy |
3,130
+235
| +8% | +$127K | 0.06% | 153 |
|
|
2023
Q1 | $1.67M | Sell |
2,895
-50
| -2% | -$28.2K | 0.07% | 150 |
|
|
2022
Q4 | $1.62M | Buy |
2,945
+425
| +17% | +$225K | 0.08% | 139 |
|
|
2022
Q3 | $1.28M | Buy |
2,520
+225
| +10% | +$126K | 0.07% | 153 |
|
|
2022
Q2 | $1.25M | Buy |
2,295
+5
| +0.2% | +$2.75K | 0.07% | 160 |
|
|
2022
Q1 | $1.35M | Sell |
2,290
-24
| -1% | -$13.8K | 0.06% | 156 |
|
|
2021
Q4 | $1.54M | Sell |
2,314
-11
| -0.5% | -$6.87K | 0.07% | 138 |
|
|
2021
Q3 | $1.33M | Buy |
2,325
+44
| +2% | +$24.1K | 0.07% | 145 |
|
|
2021
Q2 | $1.15M | Sell |
2,281
-145
| -6% | -$68.4K | 0.06% | 155 |
|
|
2021
Q1 | $1.11M | Buy |
2,426
+80
| +3% | +$38.2K | 0.06% | 141 |
|
|
2020
Q4 | $1.09M | Buy |
2,346
+146
| +7% | +$68.5K | 0.07% | 137 |
|
|
2020
Q3 | $971K | Buy |
2,200
+76
| +4% | +$31.4K | 0.07% | 129 |
|
|
2020
Q2 | $770K | Sell |
2,124
-25
| -1% | -$8.38K | 0.07% | 140 |
|
|
2020
Q1 | $609K | Buy |
2,149
+203
| +10% | +$64K | 0.07% | 135 |
|
|
2019
Q4 | $632K | Sell |
1,946
-52
| -3% | -$15.8K | 0.06% | 155 |
|
|
2019
Q3 | $582K | Buy |
1,998
+7
| +0.4% | +$2K | 0.06% | 155 |
|
|
2019
Q2 | $585K | Sell |
1,991
-107
| -5% | -$29.5K | 0.07% | 152 |
|
|
2019
Q1 | $574K | Buy |
2,098
+305
| +17% | +$75.9K | 0.07% | 150 |
|
|
2018
Q4 | $401K | Buy |
1,793
+61
| +4% | +$14.3K | 0.05% | 171 |
|
|
2018
Q3 | $423K | Buy |
+1,732
| New | +$398K | 0.06% | 172 |
|
Other funds holding TMO
Mission Wealth Management's TMO Position: Q2 2026 in Review
Mission Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 165% in Q2 2026, buying an estimated $3.77M and bringing the position to 12,598 shares worth $6.32M. The position accounts for 0.08% of the portfolio, ranked #149.
Mission Wealth Management first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Mission Wealth Management held 12,598 shares of Thermo Fisher Scientific worth $6.32M as of Q2 2026.
- Mission Wealth Management bought 7,843 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.77M.
- Thermo Fisher Scientific made up 0.08% of Mission Wealth Management's portfolio in Q2 2026, its #149 holding.
- Mission Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.